Savannah Wiegel
Savannah Wiegel distinguishes herself through a clinical translation lens that connects advanced genomic technologies to patient outcomes, leveraging her multidisciplinary background in molecular biology and narrative medicine to make complex diagnostics accessible.
Clinical Genomics Focus
Wiegel consistently examines how emerging sequencing technologies solve diagnostic challenges in pediatric and cancer care, as demonstrated in her coverage of long-read genome sequencing identifying RFX3 haploinsufficiency in a patient with autism spectrum disorder and intellectual disability. She analyzes epigenomic research uncovering new acute myeloid leukemia subgroups and associated drug sensitivities, emphasizing therapeutic implications over technical details.
Her reporting on CRISPR screening applications identifies host factors influencing HIV infection while highlighting potential antiviral targets like PI16 and PPID proteins.
Infectious Disease Applications
She connects fundamental virology research to clinical applications, covering how epitope-editing strategies and targeted antibodies could replace toxic DNA-damaging agents in stem cell therapies.
Wiegel documents rare disease research initiatives through events like CNBC Cures, featuring FDA perspectives and industry stakeholders addressing unmet medical needs. Her work on microbial ecosystems extends to gut health research and ancient human virology through coverage of Denisovan genetic studies.
Technology Translation Approach
Wiegel specializes in explaining how new biotechnologies solve specific research problems, evidenced by her reporting on bioanalytical antibodies, mass spectrometry systems, and organoid research platforms. She maintains GEN's editorial standard of clearly articulating "what technology is used, what results were achieved, and why these matter for the field".
Her conference coverage synthesizes key scientific developments while identifying actionable insights for researchers and clinicians.
Therapeutic Development Angle
She consistently frames research through therapeutic development pathways, as seen in her analysis of how elevated PI16 or PPID levels restrict aggressive HIV strains. Wiegel examines cancer treatment innovations by focusing on drug sensitivity patterns within newly identified genomic subgroups rather than cataloging mutations. Her reporting on ferroptosis-inducing silica nanoparticles demonstrates how mechanistic cancer biology research informs novel treatment approaches.
4 more health journalists.
Aislinn Antrim
Aislinn Antrim is an associate editorial director at Pharmacy Times and a journalist who connects clinical advances, regulation, and the changing role of pharmacists. She writes pharmacy-centered health coverage on chronic disease therapeutics, specialty and oncology care, workforce pressures, and advocacy. Her reporting explains FDA actions, policy shifts, drug pipelines, and the real-world effects of new evidence on patient care and pharmacy practice. She often uses interviews and expert conversations to show how pharmacists improve adherence, manage side effects, navigate access and benefits, and coordinate care with prescribers. She also covers burnout, staffing strain, and the future of pharmacy practice, with an eye on how policy and economics shape work at the dispenser.
Alex Cabrero
Alex Cabrero is an Emmy award-winning KSL TV reporter who covers where health, safety and community life meet, always focused on how decisions and events affect everyday people. He has been with KSL since 2004, bringing long experience in breaking news, public service coverage and human-centered features. His beat includes public health, emergency response, technology, local infrastructure, environment and science, framed through community well-being and resilience. He reports on issues like mental health initiatives, law enforcement staffing, environmental hazards, rescues, wildfire detection tools, land-use fights and scientific discoveries, making technical and policy details clear for a general audience. He also produces many positive, everyday-life features on families, veterans, farmers, sports and local traditions. His style is direct and conversational, often built around a central person or family whose experience carries the story across TV, digital and social platforms.
Alexandra Frost
Alexandra Frost is a freelance journalist and content marketing writer who turns expert-backed health and family guidance into clear, practical service stories. She covers consumer health, wellness, nutrition, preventive care, medical research, parenting, kids’ mental health, education, products, and lifestyle. Her reporting explains concerns such as inflammation, urinary symptoms, fiber, lung cancer screening, pain treatment, mobility, family dynamics, children’s technology use, and school readiness. She profiles clinicians and scientists, connects research to everyday decisions, and focuses on what readers should watch for, ask, or change. Frost currently writes across multiple outlets, including Good Housekeeping, Cincinnati Magazine, Wirecutter, Popular Science, Success, Healthline, Parents, Women’s Health, Reader’s Digest, Today’s Parent, the Atlantic, the Washington Post, TIME, Consumer Reports, Business Insider, and National Geographic. She also works as a freelance editor, media consultant, and content strategist.
Alexandra Pattillo
Alexandra Pattillo is a freelance journalist who pairs rigorous health and science reporting with intimate accounts of patients’ lives. She covers health, science and wellness for the BBC and other major outlets, including National Geographic, The New York Times, The Atlantic, The Guardian, Outside, CNN and Inverse. Her beat includes eating disorders, women’s health, perinatal mental health, brain health, youth sports, concussion, long-term Covid symptoms, attention, habits and behavioral science. She reports on emerging treatments such as psychedelic-assisted therapy for anorexia, testing evidence, safety and relapse risk. She explains complex research in plain language and examines how it shapes everyday choices. Her reporting uses in-depth interviews with patients, families, clinicians, researchers and coaches. Through the BBC’s Health Gap column, she also covers stigma, unequal access to care and gaps between lived experience and standard medical pathways.